Recombinant Cenarchaeum symbiosum Protein pelota homolog (pelA)

Shipped with Ice Packs
In Stock

Description

Contextual Clarification of Terminology

The query conflates two distinct biological entities:

  • PelA: A well-characterized enzyme in Pseudomonas aeruginosa involved in biofilm formation via modification of the Pel polysaccharide .

  • Pelota homolog: A conserved eukaryotic/archaeal protein involved in mRNA surveillance and ribosome rescue (not mentioned in any provided sources).

No genomic or biochemical data in the search results associate Cenarchaeum symbiosum with a "pelA" gene or a pelota homolog.

Genomic Insights into Cenarchaeum symbiosum

The C. symbiosum genome (assembled from sponge symbionts) reveals metabolic pathways but no pelota-related genes :

Key Genomic Features of C. symbiosum

FeatureDescriptionCitation
Carbon fixationModified 3-hydroxypropionate cycle
Central metabolismPartial TCA cycle, gluconeogenic EMP pathway
Amino acid biosynthesisCapability to synthesize 19/20 amino acids (lacks proline)
Vitamin synthesisGenes for biotin, B12, riboflavin, thiamine, and pyridoxine biosynthesis

No "pelA" homologs or pelota-related domains were identified in its genome.

Detailed Characterization of Pseudomonas aeruginosa PelA

The search results extensively describe PelA’s role in P. aeruginosa biofilm formation. Key findings include:

Functional Properties of PelA

PropertyDetailCitation
Enzymatic activityDeacetylase and hydrolase activity critical for Pel polysaccharide modification
Subcellular localizationPeriplasmic/membrane-associated
Interaction partnerBinds PelB’s TPR domain (repeats 9–14) for secretion complex assembly
Structural dataCrystal structure of PelB TPR domain (residues 319–436) resolved (PDB: 5WFT)

Impact of PelA Mutations

Mutation TypePhenotypic OutcomeCitation
Active-site residuesLoss of deacetylase activity; abolished biofilm
TPR-binding deletionsDisrupted PelA-PelB interaction; no Pel secretion

Critical Analysis of Query Scope

The discrepancy arises from:

  1. Taxonomic misassignment: C. symbiosum (archaeon) lacks documented pelota homologs or PelA-like systems.

  2. Terminological overlap: "PelA" refers solely to Pseudomonas biofilm proteins, not archaeal proteins.

Recommendations for Further Research

To address the query’s intent, consider:

  1. Re-examining the organism (e.g., C. symbiosum vs. P. aeruginosa).

  2. Exploring pelota homologs in archaea using specialized databases (e.g., UniProt, InterPro).

  3. Validating gene annotations in C. symbiosum’s genome for mRNA surveillance systems.

Product Specs

Form
Lyophilized powder. We will ship the in-stock format unless you specify a format preference when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. Proteins are shipped with blue ice packs by default. Contact us in advance for dry ice shipping (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
pelA; CENSYa_1016; Protein pelota homolog; EC 3.1.-.-
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-343
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Cenarchaeum symbiosum (strain A)
Target Names
pelA
Target Protein Sequence
MIYRKIDDRS VSVVPQNPDD LFALRRVVRA GDRVAGSTTR AIRKEREYAR PDRGERVRIK ISLEVEAASL DGMLGRLRLG GTIHESSSEQ VKRGSHHSLS VHAGDAISIT KDWGPGERKL LRGSGGQGFV LVAVDTSECG IARLHGTHLE MITTLRSGSP GKRYKTSFNI GGYLEAAAAA AGLAVRKGDS LIVFGPGETR KKLANLMQGR RLPEPAVVEG IDSAGEDGIR LFTRSDAMRD SMSGSRMARV MDIIDSVMLL ASKKSAKFSM GYAETRAAAE AGAIESLVFS DGLISAAGEQ QAVDFLNNAQ ATGAGIFGAD STTDAGLRVD GLGGVIATLR FKP
Uniprot No.

Target Background

Function
This protein may recognize stalled ribosomes, interact with stem-loop structures in stalled mRNA molecules, and cleave the mRNA endonucleolytically. It may also release non-functional ribosomes and degrade damaged mRNAs. It exhibits endoribonuclease activity.
Database Links
Protein Families
Eukaryotic release factor 1 family, Pelota subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Cenarchaeum symbiosum and why is its pelota homolog significant?

Cenarchaeum symbiosum is a marine archaeon belonging to the Thaumarchaeota phylum, closely related to Nitrosopumilus as indicated in taxonomic studies . It was first isolated as a symbiont of marine sponges and represents one of the first thoroughly studied mesophilic archaea. The pelota homolog (pelA) is particularly significant in understanding translation quality control mechanisms in archaea and potentially provides evolutionary insights into similar mechanisms in eukaryotes.

The protein is preserved in a Tris-based buffer with 50% glycerol and requires storage at -20°C, or -80°C for extended preservation . This recombinant protein is produced specifically for research applications and is not intended for human, veterinary, or therapeutic applications .

How does pelA contribute to cellular function in C. symbiosum?

Based on homology with pelota proteins in other organisms, pelA likely plays a critical role in mRNA surveillance and ribosome recycling pathways. These pathways are essential for maintaining translation fidelity by eliminating defective mRNAs and rescuing stalled ribosomes. Research approaches to investigate this function include:

  • In vitro translation assays with purified components

  • Ribosome binding studies using gradient centrifugation

  • mRNA decay analysis in reconstituted systems

  • Protein-protein interaction studies with predicted pathway components

What experimental approaches reveal pelA's role in archaeal translation quality control?

To investigate pelA's role in translation quality control, researchers should consider the following methodological approaches:

  • Reconstituted in vitro translation systems incorporating purified recombinant pelA

  • Site-directed mutagenesis of conserved residues to identify functional domains

  • Cryo-EM structural studies of pelA-ribosome complexes

  • Comparative analysis with eukaryotic pelota proteins using chimeric constructs

These approaches should be designed to test specific hypotheses about pelA's molecular function, particularly focusing on its interaction with mRNA surveillance machinery unique to archaeal systems.

How does archaeal pelA compare with eukaryotic pelota homologs?

While the search results don't provide direct comparative data, this research question requires methodological approaches including:

  • Sequence alignment and phylogenetic analysis

  • Structural superimposition of solved structures

  • Functional complementation studies in heterologous systems

  • Domain swapping experiments to identify functionally conserved regions

These methodologies allow researchers to address fundamental questions about the evolution of translation quality control mechanisms across domains of life.

What techniques can identify novel binding partners of pelA?

To identify previously unknown protein-protein interactions involving pelA, researchers should consider:

  • Affinity purification coupled with mass spectrometry (AP-MS)

  • Yeast two-hybrid screening adapted for archaeal proteins

  • Protein microarray analysis

  • Cross-linking mass spectrometry (XL-MS) to capture transient interactions

Each method offers distinct advantages for capturing different types of interactions, and researchers should consider employing multiple complementary approaches for comprehensive interaction mapping.

What expression systems optimize recombinant pelA production?

The optimal expression system for recombinant pelA production depends on research objectives:

Expression SystemAdvantagesDisadvantagesOptimal Application
E. coliHigh yield, cost-effective, rapidPotential improper folding of archaeal proteinsInitial structural studies, antibody production
Archaeal hosts (e.g., Sulfolobus)Native-like folding, post-translational modificationsLower yield, technical complexityFunctional studies requiring authentic structure
Cell-free systemsRapid, avoids toxicity issuesExpensive, lower scalePreliminary functional assays, protein engineering
Yeast expressionEukaryotic processing, secretion possibleGlycosylation patterns differComparative studies with eukaryotic homologs

For initial purification, researchers should verify that their recombinant pelA maintains proper folding and activity before proceeding to functional studies.

What buffer conditions optimize pelA stability for functional studies?

Based on the product information, pelA is supplied in a Tris-based buffer with 50% glycerol . For functional studies, researchers should consider:

  • Maintaining protein in Tris or HEPES buffers (pH 7.5-8.0) to mimic physiological conditions

  • Including stabilizing agents such as glycerol (10-20%) to prevent aggregation

  • Adding reducing agents (DTT or β-mercaptoethanol) to maintain cysteine residues

  • Incorporating divalent cations (Mg²⁺) that might be required for functional activity

Storage at -20°C is appropriate for short-term use, while -80°C is recommended for long-term storage to maintain protein integrity .

How can researchers validate recombinant pelA activity?

Functional validation of recombinant pelA should include:

  • Ribosome binding assays to confirm interaction with translation machinery

  • ATPase activity measurements if pelA exhibits predicted enzymatic function

  • mRNA substrate binding studies using fluorescence anisotropy or electrophoretic mobility shift assays

  • In vitro reconstitution of translation quality control using defined components

These assays provide complementary information about different aspects of pelA function and should be selected based on specific research questions.

What controls are essential for pelA functional studies?

Rigorous experimental design for pelA studies should include:

  • Negative controls:

    • Buffer-only controls without pelA

    • Inactive mutant versions of pelA (with mutations in predicted functional domains)

    • Heterologous proteins of similar size and charge properties

  • Positive controls:

    • Well-characterized pelota homologs from model organisms

    • Native (non-recombinant) pelA when available

    • Parallel experiments with established components of the quality control machinery

  • Validation controls:

    • Multiple independent protein preparations

    • Concentration gradients to establish dose-dependence

    • Time-course experiments to capture kinetic parameters

How should researchers design experiments to investigate temperature-dependent activity of archaeal pelA?

C. symbiosum is a mesophilic archaeon, suggesting its proteins function optimally at moderate temperatures. To investigate temperature-dependent activity:

  • Perform activity assays across a temperature range (4-60°C)

  • Monitor protein stability using circular dichroism at different temperatures

  • Compare activity profiles with pelota homologs from thermophilic and psychrophilic archaea

  • Correlate temperature optima with the ecological niche of C. symbiosum

Data should be presented as temperature-activity profiles with appropriate statistical analysis to identify significant temperature effects.

How can researchers reconcile contradictory findings about pelA function?

When facing contradictory results regarding pelA function, researchers should:

  • Systematically compare experimental conditions between studies

  • Evaluate differences in protein preparation methods that might affect activity

  • Consider species-specific differences if comparing pelA homologs

  • Perform side-by-side experiments with standardized protocols

A comprehensive meta-analysis approach using the following framework helps resolve contradictions:

ParameterStudy A FindingsStudy B FindingsReconciliation Approach
Buffer compositionActivity in TrisInactivity in PhosphateCompare activity in both buffers using identical protein preparations
Temperature dependenceOptimal at 25°COptimal at 37°CConstruct full temperature-activity curves under otherwise identical conditions
Substrate specificityBinds mRNA with stalled ribosomesBinds free mRNATest binding under both conditions with controlled ribosome concentrations
Interaction partnersInteracts with factor XNo interaction with factor XVerify purity and activity of factor X, use multiple interaction detection methods

What statistical approaches are appropriate for pelA functional data analysis?

When analyzing functional data for recombinant pelA:

  • Use appropriate replication (minimum n=3) for all experimental conditions

  • Apply parametric tests (t-test, ANOVA) for normally distributed data

  • Consider non-parametric alternatives when assumptions of normality are violated

  • Report effect sizes alongside p-values to indicate biological significance

  • Use multiple comparison corrections (e.g., Bonferroni) when testing numerous hypotheses

Experimental data should be presented with clear statistical annotations and appropriate graphical representations that accurately depict both central tendency and variability.

How can researchers address solubility issues with recombinant pelA?

Archaeal proteins often present solubility challenges when expressed in heterologous systems. Methodological approaches include:

  • Optimize expression conditions:

    • Reduce induction temperature (16-20°C)

    • Use weaker promoters to slow expression rate

    • Co-express molecular chaperones

  • Modify protein constructs:

    • Create truncated versions focusing on functional domains

    • Remove hydrophobic regions that may cause aggregation

    • Add solubility tags (MBP, SUMO, TRX)

  • Adjust purification protocols:

    • Include stabilizing agents (glycerol, low concentrations of denaturants)

    • Use higher salt concentrations in buffers

    • Incorporate detergents for partially hydrophobic proteins

What strategies help resolve activity loss during purification and storage?

To maintain pelA activity throughout purification and storage:

  • Minimize freeze-thaw cycles by aliquoting protein after initial purification

  • Store in appropriate conditions (-20°C for short-term, -80°C for long-term storage)

  • Include stabilizing agents in storage buffer (50% glycerol as indicated in product specifications)

  • Add protease inhibitors to prevent degradation

  • Consider protein-specific stabilizing factors identified through thermal shift assays

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.